1. Abe Y, Miyake M, Horiuchi A, Kimura S, Hitsumoto Y (1991) Expression of membrane-associated lymphotoxin/tumor necrosis factor-β on human lymphokine-activated killer cells. Jpn J Cancer Res 82: 23–26
2. Abe Y, Horiuchi A, Osuka Y, Kimura S,.Granger GA, Gatanaga T (1992) Studies of membrane-associated and soluble (secreted) lymphotoxin in human lymphokine-activated T-killer cells in vitro. Lymphokine Cytokine Res 11: 115–121
3. Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G (1991) Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 51: 5602–5607
4. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D(1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 175: 323–329
5. Aderka D, Wysenbeek A, Engelmann H, Cope AP, Brennan F, Molad Y, Hornik V, Levo Y, Maini RN, Feldmann M et al. (1993)Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 36: 1111–1120